Vol 91, No 7 (2020)
Guidelines / Expert consensus
Published online: 2020-07-31

open access

Page views 1471
Article views/downloads 1328
Get Citation

Connect on Social Media

Connect on Social Media

Possible deferral of diagnostic and therapeutic procedures for patients with abnormal screening tests results in cervical cancer secondary prevention in current SARS-CoV-2 pandemic Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology

Robert Jach1, Maciej Mazurec2, Martyna Trzeszcz3, Mariusz Zimmer4
Pubmed: 32779165
Ginekol Pol 2020;91(7):428-431.

Abstract

The Polish Society of Gynecologists and Obstetricians and Polish Society of Colposcopy and Cervical Pathophysiology Interim Guidelines goal at aiding gynecologists in providing a cervical cancer prevention care during the evolving SARS-CoV-2 pan-demic. Presented guidelines were developed on a review of limited data and updated when new relevant publications were revealed. Timing for deferrals of diagnostic-therapeutic procedures were mostly covered in the guidelines. Also, a support for the existing Polish recommendations on abnormal screening results in a subject of minor and major screening abnor-malities terminology were given. The guidelines are obligatory for the specified COVID-19 pandemic period only and they might be changed depending on the new available evidence.

Article available in PDF format

View PDF Download PDF file

References

  1. The World Health Organization. WHO Director-General's opening remarks on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (11 March 2020).
  2. Rozporządzenie Rady Ministrów z dnia 26 kwietnia 2020 r. zmieniające rozporządzenie w sprawie ustanowienia określonych ograniczeń, nakazów i zakazów w związku z wystąpieniem stanu epidemii. http://dziennikustaw gov pl/DU/2020/697 (Accessed 27 March 2020).
  3. The American Society for Colposcopy and Cervical Pathology. ASCCP Interim Guideline for Timing and Treatment Procedures for Patients with Abnormal Cervical Screening Tests. https://www.asccp.org//covid-19-resources (20 March 2020).
  4. Zalecenia dla kobiet w okresie okołoporodowym w związku z ogłoszonym na obszarze Rzeczypospolitej Polskiej stanem epidemii w związku z zakażeniami wirusem SARS-CoV-2. .https://www.gov.pl/web/zdrowie/zalecenia-dla-kobiet-w-okresie-okoloporodowym-w-zwiazku-z-zakazeniami-sars-cov-2 (20 March 2020).
  5. Rekomendowana ścieżka postępowania dla kobiet w ciąży COVID-19. https://www.ptgin.pl/rekomendowana-sciezka-postepowania-dla-kobiet-w-ciazy-covid-19 (21 March 2020).
  6. Józefiak A, Kędzia W, Kotarski J, et al. Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL). Ginekol Pol. 2013; 84: 395–399.
  7. National Cervical Cancer Screening Programme in Poland Coordinating Centre; Polish Gynaecological Society; Polish Society of Pathologists; Polish Society of Colposcopy and Uterine Cervix Pathology. Management of abnormal pap smear--consensus guidelines of the National Cervical Cancer Screening Programme in Poland Coordinating Centre, the Polish Gynaecological Society, the Polish Society of Pathologists, and Polish Society of Colposcopy and Uterine Cervix Pathology. Ginekol Pol. 2009 Feb. ; 80(2): 129–38.
  8. Nasierowska-Guttmejer A, Kędzia W, Wojtylak S, et al. Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines. Ginekol Pol. 2016; 87(9): 670–676.
  9. Winer R, Lin J, Tiro J, et al. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment. JAMA Network Open. 2019; 2(11): e1914729.
  10. European Society for Medical Oncology. Management and Treatment Adapted Recommendations in the COVID-19 Era: Cervical Cancer. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/gynaecological-malignancies-cervical-cancer-in-the-covid-19-era (10 April 2020).
  11. Ramirez PT, Chiva L, Eriksson AG, et al. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer. 2020; 30(5): 561–563.
  12. SGS, SGO, ASRM, AAGL AUGS, IGCS, SFP, SRS. Joint Statement on Re-introduction of Hospital and Office-based Procedures in the COVID-19 Climate for the Practicing Urogynecologist and Gynecologist. https://www.sgo.org/wp-content/uploads/2020/04/Reintroduction-of-Hospital-and-Office-Procedures-in-the-COVID-19-Climate.pdf (April 2020).
  13. LeBrun EW, Moawad N, Rosenberg E, et al. Coronavirus disease 2019 pandemic: staged management of surgical services for gynecology and obstetrics. American Journal of Obstetrics and Gynecology. 2020; 223(1): 85.e1–85.e19.